Germkill Indias Citrobioshield Clinical Trials Proven Effective Against Covid 19 For Use Across Hospitals

Germkill&Rsquo;S Bio Organic Product Citrobioshield Validated As Per The Icmr Guideline Has Now Proven Across Healthcare Settings For Its Anti Microbial Activity And Effective Against Spread Of Covid-19. It Is Also Been Extensively Evaluated Using International Standards Of Testing: Astm And En Standards Both In India And Abroad.The Company Stated That Citrobioshield Is Essentially An Extract Of Citrus Fruits Containing Sinensis And Citrus Reticulate: Bio Flavonoids With Effective Activity Against Sars-Cov2 Virus. It Is A Made-In-India Antimicrobial, Formulated And Manufactured In Bengaluru Proving To Be Stable Upto 108 Degree Centigrade Fulfilling The Criteria For An Ideal Disinfectant While Being Safe For The Environment, Humans And Animals.The Company Collaborated With Brains Hospital Where The Product Underwent Detailed Preclinical Testing For The Last Three Months Proving That It Could Be Used Across Healthcare Centres And High Risk Areas Where Community Is At Risk To Reduce The Viral Load In The Environment. In Addition Rajiv Gandhi Institute Of Chest Diseases The Government Facility For Covid-19 Care And Gandhi Hospital, Hyderabad Have Also Shown Positive Response Towards The Use Of The Product.It Is Recommended For Use Across Wards, Icus And Operation Theaters To Disinfect Surfaces, Beds, Instruments And Ventilator Tubings. Frequent Fogging Can Be Performed Between The Two Procedures Without Delaying The Routine Work.A Concern For Infection Transmission Has Been Ventilators Used In Covid-19 Care. Here Citrobioshield Has Shown Total Efficacy To Stall Cross Infection, Dr N K Venkataramana, Founder-Chairman &Amp; Chief Neurosurgeon, Brains Hospitals.The Product Has A Rapid Onset And Long Lasting Bactericidal, Fungicidal And Viricidal Activity. The 10% Citrobioshield Solution Was Completely Viricidal For Sars-Cov2 With A Contact Time Of 10 Minutes. It Has Been Found Effective Against Many Microorganisms Of Clinical Significance Like Methicillin Resistant Staphylococcus Aureus, Pseudomonas, Candida Albicans, E Coli ,Sars-Cov2, Hiv) In Both Laboratory And Clinical Settings, He Added.Further, Citrobioshield Retains Robust Viricidal Activity, Especially Against Sars-Cov2 On Surfaces Including Tiles And Stainless Steel. Citrobioshield Is Non Toxic And Not Harmful For Cleanroom Environments And Therefore Suitable For Bsl2 And 3 Facilities That Require Stringent Sterility Measures.The Preclinical Testing Has Shown It To Be Non-Toxic By Both Oral And Inhalation Routes. It Is Odorless, Non-Carcinogenic, Non-Mutagenic, Non-Irritant And Not Allergic. Citrobioshield Is Usually Administered As Fog Using Special Equipment, Said Dr Venkataramana."Our Citrobioshield Is A Fresh Ray Of Hope In The Fight Against The Covid 19. We Recommend That This Should Be Adopted As A Routine Sterilization Process As Well As A Preventive Measure For The Covid-19 At All Healthcare Facilities. We Sincerely Request The Union And State Governments Direct The Authorities For Its Implementation, Said Dr. R Nagaraja Naidu, Inventor And Founder, Germkill India.The Product Is Validated At Prewel Labs For Corrosive &Amp; Ignition Test Besides Assessment Of Antimicrobial Activity Using A Time-Kill Procedure And Evaluation Of Virucidal Activity In The Medical Area. Radiant Research Has Evaluated For Inhalational Toxicity Assay, Acute Oral Toxicity Test In Wistar Rats. Retroscreen Virology Has Analyzed For Virucidal Activity. Aman Integrated Solutions Has Tested For Minimum Inhibitory Concentration In Candida Albicans, E. Coli, S. Aureus, E.Fecalis, P.Aeruginosa And Salmonella. Gandhi Hospital Analysed For Growth Inhibition. Bharat Electrical Assessed For Cleanroom Suitability Across Industries. Syncorp Health Conducted The Clinical Study Registered As Ctri/2020/08/027085 By Fogging For 3 Minutes Per Day For 7 Days With 10% Solution And A Rate Of 50 Ml/Min. It Showed Fall In Neurotrophil, Lymphocyte And Eosinophil Without Impacting Respiratory Rate Not Affected

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!